Scot Roberts, PhD, Chief Scientific Officer Number Of Employees: ~57 Stage: Publicly traded Financial Snapshot: The companys market cap as of July 2026 was $548 million
Licensed alternatives for weight management include orlistat, semaglutide (Wegovy), and in some cases liraglutide (Saxenda) or naltrexone/bupropion (Mysimba)
This is especially helpful for people who have a problem with digestive issues or cannot absorb B12 through food
Paradigm Peptides currently scores highest in independent testing databases with an A rating
This rapid onset reflects how quickly the medication reaches GLP-1 receptors in the gastrointestinal tract and chemoreceptor trigger zone in the brain
Check out these amazing, high quality products from Kion, especially their essential amino acids, which we both use daily